Romain Guièze
Université Clermont Auvergne(FR)Université de Poitiers(FR)Institut de Cancérologie Strasbourg(FR)University of Clermont Auvergne(FR)Centre Hospitalier Universitaire d'Angers(FR)Dana-Farber Cancer Institute(US)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Génétique, Diversité, Écophysiologie des Céréales(FR)Clermont Université(FR)Centre Virchow-Villermé(FR)Centre Henri BecquerelUniversité d'Angers(FR)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies(2019)352 cited
- → Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia(2015)144 cited
- → Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study(2019)126 cited
- → Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study(2011)118 cited
- → Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial(2015)110 cited
- → Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL